撤稿：复方异丙托溴铵联合布地奈德吸入治疗慢性阻塞性肺疾病急性加重及其对肝素结合蛋白的影响
Retracted: Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein.
作者信息
And Alternative Medicine Evidence-Based Complementary
出版信息
Evid Based Complement Alternat Med. 2023 Dec 13;2023:9839703. doi: 10.1155/2023/9839703. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/4457740.].
摘要
[本文撤回文章DOI: 10.1155/2022/4457740。]
相似文献
1
Retracted: Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein.撤稿：复方异丙托溴铵联合布地奈德吸入治疗慢性阻塞性肺疾病急性加重及其对肝素结合蛋白的影响
Evid Based Complement Alternat Med. 2023 Dec 13;2023:9839703. doi: 10.1155/2023/9839703. eCollection 2023.
2
Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein.复方异丙托溴铵联合布地奈德吸入治疗慢性阻塞性肺疾病急性加重期及其对肝素结合蛋白的影响
Evid Based Complement Alternat Med. 2022 Jul 4;2022:4457740. doi: 10.1155/2022/4457740. eCollection 2022.
3
The effect of ventilator mask atomization inhalation of ipratropium bromide and budesonide suspension liquid in the treatment of COPD in acute exacerbation period on circulating levels of inflammation and prognosis.呼吸机雾化面罩吸入溴化异丙托品和布地奈德混悬液治疗 COPD 急性加重期对循环炎症水平和预后的影响。
Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5211-5216. doi: 10.26355/eurrev_201711_13843.
4
[Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study].[布地奈德混悬液联合沙丁胺醇及异丙托溴铵治疗儿童急性哮喘发作的疗效：一项对比研究]
Nan Fang Yi Ke Da Xue Xue Bao. 2008 Mar;28(3):470-2.
5
Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.噻托溴铵粉吸入剂：在慢性阻塞性肺疾病治疗中的应用评价。
Drugs. 2012 Jan 22;72(2):273-300. doi: 10.2165/11208620-000000000-00000.
6
Comparison of the efficacy of aerosol inhalation between the ipratropium bromide and terbutaline on the patients with AECOPD.异丙托溴铵与特布他林雾化吸入对慢性阻塞性肺疾病急性加重期患者疗效的比较。
Pak J Pharm Sci. 2019 Sep;32(5(Special)):2489-2493.
7
Use of ipratropium bromide in obstructive lung disease.异丙托溴铵在阻塞性肺疾病中的应用。
Clin Pharm. 1988 Sep;7(9):670-80.
8
Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.皮质类固醇对慢性阻塞性肺疾病中支气管扩张作用的影响。
Thorax. 1992 Aug;47(8):616-21. doi: 10.1136/thx.47.8.616.
9
Efficacy and safety of tiotropium bromide combined with budesonide/formoterol in the treatment of moderate to severe chronic obstructive pulmonary disease.噻托溴铵联合布地奈德/福莫特罗治疗中重度慢性阻塞性肺疾病的疗效与安全性
Exp Ther Med. 2018 Dec;16(6):4578-4584. doi: 10.3892/etm.2018.6773. Epub 2018 Sep 19.
10
Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease.异丙托溴铵对慢性阻塞性肺疾病大鼠模型气道和肺毒蕈碱受体的影响。
Chin Med J (Engl). 2001 Jan;114(1):80-3.
本文引用的文献
1
Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein.复方异丙托溴铵联合布地奈德吸入治疗慢性阻塞性肺疾病急性加重期及其对肝素结合蛋白的影响
Evid Based Complement Alternat Med. 2022 Jul 4;2022:4457740. doi: 10.1155/2022/4457740. eCollection 2022.
Zotero 插件